crizotinib
pfizer
['crizotinib', 'lcsm,(-blcsm)']
#asco abs 9077: cns progression on alk, ros tkis from #atomic registry by pts who develop cns mets at 2yr follow-up
14% alk (non-crizotinib tx)
47% ros need brain surveillance need for tkis w cns activity
#lcsm 
Associate Director Community Outreach- Thoracic Oncology-University of Miami @SylvesterCancer , Boricua en la Luna, Tweets are my own. (she/her)